Dilsah Ezgi Yilmaz
Overview
Explore the profile of Dilsah Ezgi Yilmaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
3
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurt S, Senol S, Yilmaz D, Bahceli O, Ozgen B, Sabrie Z, et al.
Cell Mol Biol (Noisy-le-grand)
. 2025 Jan;
70(12):52-58.
PMID: 39799497
Increasing evidence suggests that inhibition of receptor-interacting serine/threonine-protein kinase (RIPK) 1/RIPK3/mixed lineage kinase domain-like pseudokinase (MLKL) necrosome has protective effects in vivo models of painful conditions seen in humans associated...
2.
Yilmaz D, Senol S, Temiz-Resitoglu M, Sahan-Firat S, Tunctan B
Cell Mol Biol (Noisy-le-grand)
. 2023 Oct;
69(9):15-23.
PMID: 37807339
The nucleotide-binding oligomerization domain-like receptor X1 (NLRX1) has been associated with various anti-inflammatory mechanisms. We investigated whether the NLRX1 ligand docosahexaenoic acid (DHA) ameliorates lipopolysaccharide (LPS)-induced inflammatory hyperalgesia by interacting...
3.
Tunctan B, Senol S, Temiz-Resitoglu M, Yilmaz D, Guden D, Bahceli O, et al.
J Cardiovasc Pharmacol
. 2022 Mar;
80(2):276-293.
PMID: 35323151
The orphan receptor, G protein-coupled receptor (GPR) 75, which has been shown to mediate various effects of 20-hydroxyeicosatetraenoic acid (20-HETE), is considered as a therapeutic target in the treatment of...